annual EBITDA:
$21.96M+$1.16M(+5.60%)Summary
- As of today (June 2, 2025), IRMD annual EBITDA is $21.96 million, with the most recent change of +$1.16 million (+5.60%) on December 31, 2024.
- During the last 3 years, IRMD annual EBITDA has risen by +$10.74 million (+95.69%).
- IRMD annual EBITDA is now at all-time high.
Performance
IRMD EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly EBITDA:
$5.63M-$369.50K(-6.16%)Summary
- As of today (June 2, 2025), IRMD quarterly EBITDA is $5.63 million, with the most recent change of -$369.50 thousand (-6.16%) on March 31, 2025.
- Over the past year, IRMD quarterly EBITDA has increased by +$651.20 thousand (+13.09%).
- IRMD quarterly EBITDA is now -7.70% below its all-time high of $6.10 million, reached on September 30, 2023.
Performance
IRMD quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
$23.43M+$651.20K(+2.86%)Summary
- As of today (June 2, 2025), IRMD TTM EBITDA is $23.43 million, with the most recent change of +$651.20 thousand (+2.86%) on March 31, 2025.
- Over the past year, IRMD TTM EBITDA has increased by +$1.85 million (+8.56%).
- IRMD TTM EBITDA is now at all-time high.
Performance
IRMD TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
IRMD EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +5.6% | +13.1% | +8.6% |
| 3 y3 years | +95.7% | +60.3% | +85.6% |
| 5 y5 years | +122.1% | +419.9% | +158.3% |
IRMD EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +95.7% | -7.7% | +60.3% | at high | +85.6% |
| 5 y | 5-year | at high | +3669.5% | -7.7% | +315.9% | at high | +3922.3% |
| alltime | all time | at high | +3669.5% | -7.7% | +315.9% | at high | +3922.3% |
IRMD EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | $5.63M(-6.2%) | $23.43M(+2.9%) |
| Dec 2024 | $21.96M(+5.6%) | $6.00M(+0.1%) | $22.78M(+2.8%) |
| Sep 2024 | - | $5.99M(+2.8%) | $22.15M(-0.5%) |
| Jun 2024 | - | $5.83M(+17.1%) | $22.26M(+3.1%) |
| Mar 2024 | - | $4.97M(-7.3%) | $21.59M(+3.8%) |
| Dec 2023 | $20.80M(+27.6%) | $5.37M(-12.0%) | $20.80M(+5.6%) |
| Sep 2023 | - | $6.10M(+18.3%) | $19.69M(+8.4%) |
| Jun 2023 | - | $5.15M(+22.9%) | $18.16M(+2.8%) |
| Mar 2023 | - | $4.19M(-1.5%) | $17.67M(+4.0%) |
| Dec 2022 | $16.30M(+45.2%) | $4.25M(-6.9%) | $16.99M(+4.7%) |
| Sep 2022 | - | $4.57M(-2.0%) | $16.23M(+7.6%) |
| Jun 2022 | - | $4.66M(+32.8%) | $15.09M(+19.6%) |
| Mar 2022 | - | $3.51M(+0.4%) | $12.62M(+12.5%) |
| Dec 2021 | $11.22M(+1826.3%) | $3.50M(+2.0%) | $11.22M(+28.7%) |
| Sep 2021 | - | $3.43M(+56.3%) | $8.72M(+36.1%) |
| Jun 2021 | - | $2.19M(+4.0%) | $6.41M(+298.1%) |
| Mar 2021 | - | $2.11M(+113.0%) | $1.61M(+176.2%) |
| Dec 2020 | $582.70K(-94.1%) | $990.00K(-11.3%) | $582.60K(-72.4%) |
| Sep 2020 | - | $1.12M(-142.8%) | $2.11M(-44.5%) |
| Jun 2020 | - | -$2.61M(-340.8%) | $3.80M(-58.1%) |
| Mar 2020 | - | $1.08M(-57.1%) | $9.07M(-8.3%) |
| Dec 2019 | $9.89M(+39.1%) | $2.52M(-10.3%) | $9.89M(+5.0%) |
| Sep 2019 | - | $2.81M(+5.5%) | $9.42M(+16.6%) |
| Jun 2019 | - | $2.66M(+40.0%) | $8.08M(+7.8%) |
| Mar 2019 | - | $1.90M(-7.4%) | $7.49M(+5.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2018 | $7.11M(+174.1%) | $2.05M(+40.3%) | $7.11M(+11.2%) |
| Sep 2018 | - | $1.46M(-29.6%) | $6.39M(+17.0%) |
| Jun 2018 | - | $2.08M(+37.1%) | $5.46M(+34.6%) |
| Mar 2018 | - | $1.52M(+13.3%) | $4.06M(+56.5%) |
| Dec 2017 | $2.59M(-78.2%) | $1.34M(+150.5%) | $2.59M(-13.7%) |
| Sep 2017 | - | $534.00K(-20.7%) | $3.01M(-46.8%) |
| Jun 2017 | - | $673.30K(+1282.5%) | $5.65M(-32.6%) |
| Mar 2017 | - | $48.70K(-97.2%) | $8.38M(-29.4%) |
| Dec 2016 | $11.88M(-3.6%) | $1.75M(-44.9%) | $11.88M(-15.9%) |
| Sep 2016 | - | $3.18M(-6.5%) | $14.12M(-0.6%) |
| Jun 2016 | - | $3.40M(-4.0%) | $14.20M(+4.8%) |
| Mar 2016 | - | $3.54M(-11.3%) | $13.55M(+10.0%) |
| Dec 2015 | $12.32M(+283.2%) | $4.00M(+22.6%) | $12.32M(+43.3%) |
| Sep 2015 | - | $3.26M(+18.6%) | $8.60M(+48.5%) |
| Jun 2015 | - | $2.75M(+18.7%) | $5.79M(+23.6%) |
| Mar 2015 | - | $2.32M(+742.7%) | $4.69M(+45.8%) |
| Dec 2014 | $3.21M(+9.9%) | $274.80K(-39.1%) | $3.21M(-13.2%) |
| Sep 2014 | - | $451.50K(-72.5%) | $3.70M(+1.7%) |
| Jun 2014 | - | $1.64M(+94.6%) | $3.64M(+29.6%) |
| Mar 2014 | - | $844.90K(+10.6%) | $2.81M(-4.0%) |
| Dec 2013 | $2.93M(+91.1%) | $763.90K(+96.6%) | $2.93M(+35.3%) |
| Sep 2013 | - | $388.60K(-52.2%) | $2.16M(+21.9%) |
| Jun 2013 | - | $812.90K(-15.4%) | $1.77M(+84.6%) |
| Mar 2013 | - | $960.80K | $960.80K |
| Dec 2012 | $1.53M | - | - |
FAQ
- What is IRadimed annual EBITDA?
- What is the all time high annual EBITDA for IRadimed?
- What is IRadimed annual EBITDA year-on-year change?
- What is IRadimed quarterly EBITDA?
- What is the all time high quarterly EBITDA for IRadimed?
- What is IRadimed quarterly EBITDA year-on-year change?
- What is IRadimed TTM EBITDA?
- What is the all time high TTM EBITDA for IRadimed?
- What is IRadimed TTM EBITDA year-on-year change?
What is IRadimed annual EBITDA?
The current annual EBITDA of IRMD is $21.96M
What is the all time high annual EBITDA for IRadimed?
IRadimed all-time high annual EBITDA is $21.96M
What is IRadimed annual EBITDA year-on-year change?
Over the past year, IRMD annual EBITDA has changed by +$1.16M (+5.60%)
What is IRadimed quarterly EBITDA?
The current quarterly EBITDA of IRMD is $5.63M
What is the all time high quarterly EBITDA for IRadimed?
IRadimed all-time high quarterly EBITDA is $6.10M
What is IRadimed quarterly EBITDA year-on-year change?
Over the past year, IRMD quarterly EBITDA has changed by +$651.20K (+13.09%)
What is IRadimed TTM EBITDA?
The current TTM EBITDA of IRMD is $23.43M
What is the all time high TTM EBITDA for IRadimed?
IRadimed all-time high TTM EBITDA is $23.43M
What is IRadimed TTM EBITDA year-on-year change?
Over the past year, IRMD TTM EBITDA has changed by +$1.85M (+8.56%)